Add
HTWR to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| HTWR > SEC Filings for HTWR > Form 8-K on 7-Jan-2013 | All Recent SEC Filings |
7-Jan-2013
Results of Operations and Financial Condition, Regulation FD Disclo
On January 7, 2013, HeartWare International, Inc. (NASDAQ: HTWR-ASX: HIN), announced that it expects total revenues for the fourth quarter of 2012 will be approximately $32 million, bringing expected full-year 2012 revenues to approximately $110 million.
These preliminary results are being provided in conjunction with the Company's presentation to the investment community at the 31st Annual J.P. Morgan Healthcare Conference. HeartWare's presentation commences at 10:30 a.m. Pacific Standard Time (1:30 p.m. EST) on January 7, 2013 at the Westin St. Francis Hotel in San Francisco. A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com. A replay of the webcast will be available for 90 days at the site after the presentation.
The financial estimates presented are preliminary and remain subject to management's final review as well as audit by the Company's independent registered accounting firm. The Company intends to report complete fourth quarter and full-year 2012 financial results in late February. Details regarding the timing of the release of those results, as well as details of a conference call and publically available webcast, will be announced in a subsequent news release.
The information in this Item 2.02 to Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
A copy of the release issued by HeartWare is furnished with this report as Exhibit 99.1.
A copy of the release issued by HeartWare is furnished with this report as Exhibit 99.1.
The information in this Item 7.01 to Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Exhibit No. Description
99.1 Press Release issued by HeartWare International, Inc. dated
January 7, 2013.
|
|
|